“Assessment of Dapagliflozin Effectiveness As Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”. Academia Journal of Medicine 4, no. 2 (December 31, 2022): 50–54. Accessed November 21, 2024. https://medjournal.co.in/index.php/ajm/article/view/82.